CCWM
PFE icon

Cassaday & Co Wealth Management’s Pfizer PFE Stock Holding History

Cassaday & Co Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$713K Buy
29,619
+734
+3% +$19.2K 0.01% 185
2026
Q1 		$811K Sell
28,885
-158
-0.5% -$4.21K 0.02% 161
2025
Q4 		$723K Sell
29,043
-138
-0.5% -$3.48K 0.02% 177
2025
Q3 		$744K Buy
29,181
+290
+1% +$7.16K 0.02% 172
2025
Q2 		$700K Buy
28,891
+1,009
+4% +$23.5K 0.02% 171
2025
Q1 		$707K Sell
27,882
-161
-0.6% -$4.21K 0.02% 157
2024
Q4 		$744K Sell
28,043
-5,467
-16% -$148K 0.02% 152
2024
Q3 		$970K Sell
33,510
-2,408
-7% -$70.2K 0.03% 116
2024
Q2 		$1M Sell
35,918
-3,891
-10% -$107K 0.03% 101
2024
Q1 		$1.1M Buy
39,809
+959
+2% +$26.6K 0.04% 93
2023
Q4 		$1.12M Sell
38,850
-5,839
-13% -$177K 0.04% 92
2023
Q3 		$1.48M Buy
44,689
+2,690
+6% +$95.1K 0.06% 67
2023
Q2 		$1.54M Sell
41,999
-3,289
-7% -$128K 0.06% 66
2023
Q1 		$1.85M Buy
45,288
+309
+0.7% +$13.3K 0.08% 53
2022
Q4 		$2.3M Buy
+44,979
New +$2.16M 0.11% 46

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cassaday & Co Wealth Management's PFE Position: Q2 2026 in Review

Cassaday & Co Wealth Management increased its Pfizer (PFE) stake by 2.5% in Q2 2026, buying an estimated $19.2K and bringing the position to 29,619 shares worth $713K. The position accounts for 0.01% of the portfolio, ranked #185.

Cassaday & Co Wealth Management first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.3M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cassaday & Co Wealth Management held 29,619 shares of Pfizer worth $713K as of Q2 2026.
  • Cassaday & Co Wealth Management bought 734 Pfizer shares in Q2 2026, an estimated $19.2K.
  • Pfizer made up 0.01% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #185 holding.
  • Cassaday & Co Wealth Management first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Cassaday & Co Wealth Management's Pfizer position peaked at $2.3M in Q4 2022.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.